NCI 10479: A phase I dose escalation-expansion trial of sunitinib malate plus lutetium (Lu-177) dotatate in somatostatin receptor positive pancreatic neuroendocrine tumors.
Authors: Nikolaos Trikalinos, Haeseong Park, Hyun Kim, Vikas Prasad, Feng Gao, Lorraine Cheryl Pelosof, Amir Iravani, Manik A. Amin, Kian-Huat Lim